|
| Press Releases |
|
 |
|
| Tuesday, November 9, 2021 |
|
|
醫思健康發佈正面盈利預告 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）發佈正面盈利預告，預計集團截至2021年9月30日止的六個月（簡稱「期內」）之未經審計收入及稅後溢利較2020年同期預期大幅上升分別60%以上及200%以上。 more info >> |
|
|
EC Healthcare Announced Positive Profit Alert |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, announced a positive profit alert. The Group expected to record a significant increase of over 60% in revenue and over 200% in profit after tax six months ended 30 September 2021 (the "Reporting Period") respectively as compared to that of the corresponding period in 2020. more info >> |
|
| Monday, November 8, 2021 |
|
|
医思健康收购香港专科医疗中心 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，收购进汇医务中心（「目标公司」）70%已发行股本，总代价将以现金支付，总计1亿港元。 more info >> |
|
|
醫思健康收購香港專科醫療中心 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，收購進匯醫務中心（「目標公司」）70%已發行股本，總代價將以現金支付，總計1億港元。 more info >> |
|
|
EC Healthcare Acquires Specialty Medical Services Centers in Hong Kong |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group enters into a sales and purchase agreement to acquire 70% of the issued share capital of Premier Medical Group (BVI) Limited (the "Target Company"), for a total consideration of HK$100 million in cash. more info >> |
|
| Monday, October 11, 2021 |
|
|
医思健康预计2021/22上半财年销售数据创新高 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团预计截至2021年4-9月之销售数据创新高。 more info >> |
|
|
醫思健康預計2021/22上半財年銷售數據創新高 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團預計截至2021年4-9月之銷售數據創新高。 more info >> |
|
|
EC Healthcare expects to achieve a record-high sales volume in first half of FY21/22 |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the Group's expected to achieve a record-high sales volume from April to September 2021(the "Reporting Period").
more info >> |
|
| Monday, August 16, 2021 |
|
|
医思健康收购连锁兽医医院 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」;香港联交所股份编号：2138）欣然宣布，收购香港连锁兽医医院（「该等目标公司」）全部已发行股本，总代价将以现金支付。 more info >> |
|
|
醫思健康收購連鎖獸醫醫院 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，收購香港連鎖獸醫醫院（「該等目標公司」）全部已發行股本，總代價將以現金支付。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 6, 2026 19:56 HKT/SGT
|
|
|
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
Feb 6, 2026 17:45 HKT/SGT
|
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 6, 2026 17:01 HKT/SGT
|
|
|
歌禮製藥-B（01672）獲新加坡政府投資公司首次入股 涉資約1億美元
Feb 6, 2026 16:56 HKT/SGT
|
|
|
歌礼制药-B（01672）获新加坡政府投资公司首次入股 涉资约1亿美元
Feb 6, 2026 16:50 HKT/SGT
|
|
|
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
Feb 6, 2026 16:34 HKT/SGT
|
|
|
トヨタ、役員人事を発表
Feb 6, 2026 16:00: JST
|
|
|
牧原股份港股上市：全球生豬养殖龍頭 價值成長兼具
Feb 6, 2026 15:08 HKT/SGT
|
|
|
牧原股份港股上市：全球生猪养殖龙头 价值成长兼具
Feb 6, 2026 15:01 HKT/SGT
|
|
|
優異供應鏈賦能與國際化佈局雙輪驅動 綠茶開啟高質量成長新篇章
Feb 6, 2026 14:47 HKT/SGT
|
|
|
优异供应链赋能与国际化布局双轮驱动 绿茶开启高质量成长新篇章
Feb 6, 2026 14:33 HKT/SGT
|
|
|
雲頂新耀維適平(R)獲中國國家藥品監督管理局批准上市 為中重度潰瘍性結腸炎治療提供新選擇
Feb 6, 2026 14:11 HKT/SGT
|
|
|
云顶新耀维适平(R)获中国国家药品监督管理局批准上市 为中重度溃疡性结肠炎治疗提供新选择
Feb 6, 2026 14:03 HKT/SGT
|
|
|
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025
Feb 6, 2026 13:13 HKT/SGT
|
|
|
「工業數智化引擎」卡奧斯衝擊港交所 激活製造業新动能
Feb 6, 2026 12:45 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
